These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7046924)

  • 21. [Clinical application and the technical procedure of plasmapheresis].
    Gurland HJ; Samtleben W
    Internist (Berl); 1983 Jan; 24(1):14-26. PubMed ID: 6341277
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoimmune diseases of the nervous system.
    Behan PO; Johnson RH
    Practitioner; 1975 Apr; 214(1282):522-532. PubMed ID: 1096126
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma exchange in neurological diseases.
    Behan PO; Behan WM
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):283-4. PubMed ID: 3115412
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic aspects of neurological and neuromuscular diseases.
    Zweiman B; Levinson AI
    JAMA; 1992 Nov; 268(20):2918-22. PubMed ID: 1433709
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma exchange in the treatment of patients with immunoneurologic disorders].
    Balint B; Radović M; Jovicić A; Apostolski S; Milenković L; Taseski J
    Vojnosanit Pregl; 1990; 47(5):348-51. PubMed ID: 2288110
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A; Fornádi L; Vájlok M
    Orv Hetil; 1988 Jan; 129(3):119-23. PubMed ID: 3281091
    [No Abstract]   [Full Text] [Related]  

  • 28. [Plasmapheresis in neurology -- personal experience].
    Załeska B; Domzał T; Korsak J
    Neurol Neurochir Pol; 1994; 28(2):167-74. PubMed ID: 8047226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience with regard to the use of plasmapheresis in pathologies of resuscitative importance].
    Capellaro L; Lupo F; Tiboldo F; Belotti MT; Spagarino E
    Minerva Med; 1987 Nov; 78(21):1565-70. PubMed ID: 3683952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study.
    Lin Y; Oji S; Miyamoto K; Narita T; Kameyama M; Matsuo H
    Ther Apher Dial; 2023 Feb; 27(1):123-135. PubMed ID: 35765859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative assessment and preparation of patients with neurologic disorders.
    Palibrk I; Kalezić N; Vucetić C; Dimitrijević I; Arsenijević V; Stefanova E
    Acta Chir Iugosl; 2011; 58(2):137-42. PubMed ID: 21879663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Review. The status of plasmapheresis and apheresis].
    Schmitt E; Klinkmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):291-309. PubMed ID: 2428704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of treatment with plasmapheresis in myasthenic crisis and severe polyneuropathy].
    Usnarska-Zubkiewicz L; Bilińska M; Gruszka E
    Pol Arch Med Wewn; 1991 Dec; 86(6):416-9. PubMed ID: 1819792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
    Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
    Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasmapheresis in myasthenia gravis].
    Puig Domingo ML; Illa Sendra I; Madoz Resano P; Net Castel A
    Med Clin (Barc); 1986 Mar; 86(12):516-20. PubMed ID: 3713321
    [No Abstract]   [Full Text] [Related]  

  • 37. [Positive effect of physical training in neuromuscular diseases. Training programs must be adapted to the underlying pathology].
    Grimby G
    Lakartidningen; 2004 Jun; 101(23):2008-12. PubMed ID: 15232838
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma-separation in myasthenia gravis: a new method of rapid plasma exchange.
    Samtleben W; Besinger UA; Toyka KV; Fateh-Moghadam A; Brehm G; Gurland HJ
    Klin Wochenschr; 1980 Jan; 58(1):47-9. PubMed ID: 6154830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasmapheresis in the treatment of nervous system diseases].
    Zaleska B
    Neurol Neurochir Pol; 1984; 18(5):409-13. PubMed ID: 6527723
    [No Abstract]   [Full Text] [Related]  

  • 40. Dysimmune neurologic disorders.
    Mascarella JJ; Hudson DC
    AACN Clin Issues Crit Care Nurs; 1991 Nov; 2(4):675-84. PubMed ID: 1954056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.